Double heterozygosity of novel variants found in patients with severe clinical phenotype of cardiovascular disorders

References

• Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125:188–197.
   PubMed Web of Science ®Google Scholar
• Mendis S, Puska P, Norrving B. Global atlas on cardiovascular disease prevention and control. Geneva (Switzerland): World Health Organization; 2011. p. 3–18.
   Google Scholar
• Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the council on clinical cardiology, heart failure and transplantation committee. Circulation. 2006;113(14):1807–1816.
   PubMed Web of Science ®Google Scholar
• Jarcho JA, McKenna W, Pare JA, et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med. 1989;321:1372–1378.
   PubMed Web of Science ®Google Scholar
• Kathiresan S, Srivastava D. Genetics of human cardiovascular disease. Cell. 2012;148(6):1242–1257.
   PubMed Web of Science ®Google Scholar
• Ashley EA, Hershberger RE, Caleshu C, et al. Genetics and cardiovascular disease: a policy statement from the American Heart Association. Circulation. 2012;126(1):142–157.
   PubMed Web of Science ®Google Scholar
• Schäffer AA. Digenic inheritance in medical genetics. J Med Genet. 2013;50:641–652.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Revenga L, Badenas C, Carrió A, et al. Elastin mutation screening in a group of patients affected by vascular abnormalities. Pediatr Cardiol. 2005;26:827–831.
   PubMed Web of Science ®Google Scholar
• Merla G, Brunetti-Pierri N, Piccolo P, et al. Supravalvular aortic stenosis: elastin arteriopathy. Circ Cadiovasc Genet. 2012;5(6):692–696.
   PubMed Web of Science ®Google Scholar
• Gellens ME, George AL Jr, Chen LQ, et al. Primary structure and functional expression of the human cardiac tetrodotoxin-insensitive voltage-dependent sodium channel. Proc Natl Acad Sci USA. 1992;89(2):554–558.
   PubMed Web of Science ®Google Scholar
• Betzenhauser MJ, Pitt GP, Antzelevitch C. Calcium channel mutations in cardiac arrhythmia syndromes. Curr Mol Pharmacol. 2015;8(2):133–142.
   PubMed Web of Science ®Google Scholar
• Urban Z, Michels VV, Thibodeau SN, et al. Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum Genet. 1999;104(2):135–142.
   PubMed Web of Science ®Google Scholar
• Metcalfe K, Rucka AK, Smoot L, et al. Elastin: mutational spectrum in supravalvular aortic stenosis. Eur J Hum Genet. 2000;8(12):955–963.
   PubMed Web of Science ®Google Scholar
• Micale, L, Turturo, MG, Fusco C, et al. Identification and characterization of seven novel mutations of elastin gene in a cohort of patients affected by supravalvular aortic stenosis. Eur J Hum Genet. 2010;18:317–323.
   PubMed Web of Science ®Google Scholar
• Jelsig AM, Urban Z, Hucthagowder V, et al. Novel ELN mutation in a family with supravalvular aortic stenosis and intracranial aneurysm. Eur J Med Genet. 2017;60(2):110–113.
   PubMed Web of Science ®Google Scholar
• Tan HL, Bink-Boelkens MT, Bezzina CR, et al. A sodium-channel mutation causes isolated cardiac conduction disease. Nature. 2001;409:1043–1047.
   PubMed Web of Science ®Google Scholar
• Lupoglazoff JM, Cheav T, Baroudi G, et al. Homozygous SCN5A mutation in long-QT syndrome with functional two-to-one atrioventricular block. Circ Res. 2001;89(2):e16–e21.
   PubMed Web of Science ®Google Scholar
• Bezzina CR, Rook MB, Groenewegen WA, et al. Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system. Circ Res. 2003;92(2):159–168.
   PubMed Web of Science ®Google Scholar
• Remme CA, Bezzina CR. Sodium channel (dys)function and cardiac arrhythmias. Cardiovasc Ther. 2010;28(5):287–294.
   PubMed Web of Science ®Google Scholar
• Splawski I, Timothy KW, Sharpe LM, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell. 2004;119(1):19–31.
   PubMed Web of Science ®Google Scholar
• Tang ZZ, Liang MC, Lu S, et al. Transcript scanning reveals novel and extensive splice variations in human l-type voltage-gated calcium channel, Cav1.2 alpha1 subunit. J Biol Chem. 2004;279(43):44335–44343.
   PubMed Web of Science ®Google Scholar
• Fukuyama M, Ohno S, Wang Q, et al. L-type calcium channel mutations in Japanese patients with inherited arrhythmias. Circ J. 2013;77(7):1799–1806.
   PubMed Web of Science ®Google Scholar
• Priganc M, Zigova M, Boronova I, et al. Analysis of SCN5A gene variants in East Slovak patients with cardiomyopathy. J Clin Lab Anal. 2016 [cited 2017 Nov 26];31:e22037. DOI:10.1002/jcla.22037
   Web of Science ®Google Scholar
• Ingles J, Doolan A, Chiu C, et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet. 2005 [cited 2017 Nov 26];42 (10): e59. DOI:10.1136/jmg.2005.033886
   PubMed Web of Science ®Google Scholar
• van Rijsingen IA, Hermans-van Ast JF, Arens YH, et al. Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?. Neth Heart J. 2009;17(12):458–463.
   PubMed Web of Science ®Google Scholar
• Tsoutsman T, Bagnall RD, Semsarian C. Impact of multiple gene mutations in determining the severity of cardiomyopathy and heart failure. Clin Exp Pharmacol Physiol. 2008;35:1349–1357.
   PubMed Web of Science ®Google Scholar
• Xu T, Yang Z, Vatta M, et al. Compound and digenic heterozygosity contributes to arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol. 2010;55(6):587–597.
   PubMed Web of Science ®Google Scholar